Basilic Fly Studio Raises INR 85 Crore Through QIP to Fuel Global Expansion

Chennai (Tamil Nadu) [India], September 20: Basilic Fly Studio Limited (BFS), a pioneering force in the world of visual effects (VFX), has successfully raised ₹84.99 crore via a Qualified Institutional Placement (QIP). The company issued 20.25 lakh equity shares, priced at ₹419.72 per share, inclusive of a premium of ₹409.72.

Fundraising Highlights:

  • Number of shares allotted: 20,25,000 equity shares
  • Face value: ₹10 per share
  • Issue price: ₹419.72 per share (including a premium of ₹409.72)
  • Discount: 5% to the floor price as per SEBI ICDR Regulations
  • Total fund raised: ₹84.99 Cr

 Institutional Allottees Receiving More Than 5% of Total QIP Allotment :

  • Astorne Capital VCC – Arven: 2,38,500 shares (11.78%)
  • Vikasa India EIF I Fund – Incube Global Opportunities: 1,90,800 shares (9.42%)
  • Astorne Capital VCC – Alpha A2: 1,43,100 shares (7.07%)
  • Rajasthan Global Securities Pvt Ltd: 1,43,100 shares (7.07%)
  • Dovetail India Fund – Class 8 Shares: 1,20,000 shares (5.93%)
  • Moneywise Financial Services Pvt Ltd: 1,19,400 shares (5.90%)
  • North Star Opportunities Fund VCC – Lighthouse Capital: 1,19,100 shares (5.88%)
  • Beacon Stone Capital VCC – Beacon Stone I: 1,19,100 shares (5.88%)

The proceeds from the QIP will strengthen the company’s balance sheet, enhance financial flexibility, and support its strategic priorities. These include investing in advanced VFX technologies, expanding delivery capabilities, building creative talent, and pursuing growth opportunities in international markets. The company remains committed to consolidating its leadership in the global VFX industry by driving innovation, operational excellence, and long-term value creation.

Commenting on this, Mr. Balakrishnan, Managing Director & CEO of Basilic Fly Studio Limited said

“The successful completion of this QIP provides us with the financial strength to accelerate our global growth strategy. We are encouraged by the overwhelming response, particularly with 57% participation from foreign portfolio investors. With this support, we plan to strengthen our teams in London and Paris, while transitioning select roles to India to further enhance efficiency and margins. The proceeds will also enable us to expand our infrastructure, including render farms and advanced AI-driven technologies, positioning us to take on large-scale projects with global studios such as Netflix, Warner Brothers, Sony, and Paramount. The strong institutional participation reflects their confidence in our vision, execution capabilities, and commitment to long-term value creation.”

If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.

Business

Fischer Medical Subsidiary, Time Medical India, Collaborates with Dr. Cherian to Pioneer Next-Generation AI-Enabled MRI System

Mumbai (Maharashtra) [India], November 4: Fischer Medical Ventures Limited (FISCHER | 524743 | INE771F01041), Time Medical International Ventures (I) P LTD, the wholly owned subsidiary of Fischer Medical Ventures Limited, today announced a strategic collaboration with globally acclaimed neurosurgeon, educator, and innovator Dr Iype Cherian. The collaboration’s sole purpose is the development of DRIS–iMRI Medharanya, a […]

Read More
Agartala Business Dr. Saikat Kar innovation Neurotech Startup Science

From Agartala to Global Innovation: How Tripura’s First Neurotech Startup is Bridging Brain Science with Grassroots Impact

Agartala (Tripura) [India], November 4: In a region celebrated for tea gardens and handicrafts rather than technological ambition, a quiet revolution is unfolding. Codonmind Nexus Private Limited, the Northeast’s pioneering neurotechnology startup, is developing brain-computer interface devices and advanced neurological research tools positioned to compete with national players in a market projected to reach USD […]

Read More
Business Harsheep Hortico Limited

Harshdeep Hortico Reports Strong H1 FY26 with Net Profit of INR 5.7 crore

Mumbai (Maharashtra) [India], November 4: Harsheep Hortico Limited (BSE: HARSHDEEP), specializing in the manufacture and export of pots, planters, garden accessories, and outdoor furniture; announced its Unaudited financials for H1 FY26. Key H1 FY25 Financial Highlights Key Financial Highlights (Consolidated) – H1 FY2025-26 Revenue for H1 FY2025–26 was ₹37.84 crore, compared to ₹24.09 crore in […]

Read More